CMET-37. SAFETY AND EFFICACY OF INTRAVENTRICULAR BIOLOGIC AGENTS AS PART OF A MULTI-AGENT INTRAVENTRICULAR TREATMENT REGIMEN FOR PATIENTS WITH NEOPLASTIC MENINGITIS